Skip to main content
Top
Published in: Heart and Vessels 10/2021

01-10-2021 | Heart Failure | Original Article

Cardiac rehabilitation after catheter ablation of atrial fibrillation in patients with left ventricular dysfunction

Authors: Daisetsu Aoyama, Shinsuke Miyazaki, Kanae Hasegawa, Moeko Nagao, Shota Kakehashi, Moe Mukai, Takayuki Sekihara, Minoru Nodera, Tomoya Eguchi, Takayoshi Aiki, Junya Yamaguchi, Yuichiro Shiomi, Naoto Tama, Hiroyuki Ikeda, Kentaro Ishida, Hiroyasu Uzui, Hiroshi Tada

Published in: Heart and Vessels | Issue 10/2021

Login to get access

Abstract

Few studies have examined the efficacy and safety of cardiac rehabilitation in patients with atrial fibrillation (AF) who underwent AF ablation. We explored the feasibility of additional cardiac rehabilitation after AF ablation in patients with a reduced left ventricular ejection fraction (LVEF). Fifty-four patients with heart failure (HF) and a reduced LVEF (HFrEF) (LVEF < 50%; 67.1 ± 11.6 years; 43 men) who underwent initial AF ablation procedures were included. Fourteen (25.9%) patients underwent cardiac rehabilitation (rehabilitation-group) and the remaining 40 (74.1%) did not (non-rehabilitation-group) after the procedure. The rehabilitation-group patients were relatively older, more likely female (p = 0.024), and had more likely a history of an HF hospitalization (p < 0.01) and cardiac device implantation (p = 0.041). The baseline LVEF was significantly lower (p = 0.043) and brain natriuretic peptide (BNP) (p < 0.01) and C-reactive protein (CRP) (p < 0.01) values were significantly higher in the rehabilitation-group. The 6-min walk distance significantly improved after 21.4 ± 11.5 days of cardiac rehabilitation during hospitalization (226.1 ± 155.9 vs. 398.1 ± 77.5 m, p = 0.016) without any adverse events. During an 18.9 ± 6.3 month follow-up period, the freedom from AF recurrence (p = 0.52) and re-hospitalizations due to HF (p = 0.63) were similar between the 2 groups. No death or strokes were observed. During the follow-up period, the LVEF significantly improved similarly in both groups, and the change in the BNP and CRP values significantly decreased in the rehabilitation-group. Despite the rehabilitation-group patients having a more severe HF status, the clinical outcomes and AF freedom were similar between the 2 groups, suggesting the favorable impact of cardiac rehabilitation after AF ablation in HFrEF patients.
Literature
1.
go back to reference Wilke T, Groth A, Muller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Bauersachs R, Breithardt G (2013) Incidence and prevalence of atrial fibrillation: an analysis based on 83 million patients. Europace 15(4):486–493CrossRef Wilke T, Groth A, Muller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Bauersachs R, Breithardt G (2013) Incidence and prevalence of atrial fibrillation: an analysis based on 83 million patients. Europace 15(4):486–493CrossRef
2.
go back to reference Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MF, Naghavi M, Mensah GA, Ezzati M, Murray CJ (2014) Worldside epidemiology of atrial fibrillation: a Grobal Burden of Disease 2010 Study. Circulation 129(8):837–847CrossRef Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MF, Naghavi M, Mensah GA, Ezzati M, Murray CJ (2014) Worldside epidemiology of atrial fibrillation: a Grobal Burden of Disease 2010 Study. Circulation 129(8):837–847CrossRef
3.
go back to reference Steven D, Rostock T, Lutomsky B, Klemm H, Servatius H, Drewitz I, Friedrichs K, Ventura R, Meinertz T, Willems S (2008) What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. Eur Heart J 29(8):1037–1042CrossRef Steven D, Rostock T, Lutomsky B, Klemm H, Servatius H, Drewitz I, Friedrichs K, Ventura R, Meinertz T, Willems S (2008) What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. Eur Heart J 29(8):1037–1042CrossRef
4.
go back to reference Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 133(17):1637–1644CrossRef Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A (2016) Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation 133(17):1637–1644CrossRef
5.
go back to reference Calkins H, Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm 33(5):369–409CrossRef Calkins H, Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T (2017) 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm 33(5):369–409CrossRef
6.
go back to reference Ichijo S, Miyazaki S, Kusa S, Nakamura H, Hachiya H, Kajiyama T, Iesaka Y (2018) Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure. J Cardiol 72(3):240–246CrossRef Ichijo S, Miyazaki S, Kusa S, Nakamura H, Hachiya H, Kajiyama T, Iesaka Y (2018) Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure. J Cardiol 72(3):240–246CrossRef
7.
go back to reference Friberg L, Tabrizi F, Englund A (2016) Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 37(31):2478–2487CrossRef Friberg L, Tabrizi F, Englund A (2016) Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 37(31):2478–2487CrossRef
8.
go back to reference Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61(18):1894–1903CrossRef Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, McDonagh TA, Underwood SR, Markides V, Wong T (2013) A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol 61(18):1894–1903CrossRef
9.
go back to reference Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y (2020) Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Resitry. Heart Vessels. https://doi.org/10.1007/S00380-020-01721-xCrossRefPubMed Iso K, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Hayashi H, Iwasaki YK, Shimizu W, Nakajima I, Harada T, Koyama J, Okumura K, Tokuda M, Yamane T, Tanimoto K, Momiyama Y, Nonoguchi N, Soejima K, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Yazaki Y, Satomi K, Watari Y, Okumura Y (2020) Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Resitry. Heart Vessels. https://​doi.​org/​10.​1007/​S00380-020-01721-xCrossRefPubMed
10.
go back to reference Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjaerpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate conticuous training in heart failure patients: arandomized study. Circulation 115(24):3086–3094CrossRef Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjaerpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate conticuous training in heart failure patients: arandomized study. Circulation 115(24):3086–3094CrossRef
11.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef
12.
go back to reference Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaëlsson K, Sundström J (2013) Risk of arrhythmia in 52755 long-distance cross-country sikers: a cohort study. Eur Heart J 34(47):3624–3631CrossRef Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michaëlsson K, Sundström J (2013) Risk of arrhythmia in 52755 long-distance cross-country sikers: a cohort study. Eur Heart J 34(47):3624–3631CrossRef
13.
go back to reference Ayinde H, Schweizer ML, Crabb V, Ayinde A, Abugroun A, Hopson J (2018) Age modifies the risk of atrial fibirillation among athlets: a systematic literature review and meta-analysis. Int J Cardiol Heart Vasc 18:25–29PubMedPubMedCentral Ayinde H, Schweizer ML, Crabb V, Ayinde A, Abugroun A, Hopson J (2018) Age modifies the risk of atrial fibirillation among athlets: a systematic literature review and meta-analysis. Int J Cardiol Heart Vasc 18:25–29PubMedPubMedCentral
14.
go back to reference Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg Jm Froelicher VF, Leon AS, Piña IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T (2001) Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104(14):1694–1740CrossRef Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg Jm Froelicher VF, Leon AS, Piña IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T (2001) Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104(14):1694–1740CrossRef
15.
go back to reference Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B, Limacher M, Piña IL, Stein RA, Williams M, Bazzarre T (2000) AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation 101(7):828–833CrossRef Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B, Limacher M, Piña IL, Stein RA, Williams M, Bazzarre T (2000) AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation 101(7):828–833CrossRef
16.
go back to reference ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117CrossRef
17.
go back to reference Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS (2005) Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation 111(3):369–376CrossRef Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS (2005) Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation 111(3):369–376CrossRef
18.
go back to reference Piepoli MF, Davos C, Francis DP, Coats AJ (2004) Exercise training meta-analysis of traials in patinets with chronic heart failure (ExTraMATCH). BMJ 328(7433):189CrossRef Piepoli MF, Davos C, Francis DP, Coats AJ (2004) Exercise training meta-analysis of traials in patinets with chronic heart failure (ExTraMATCH). BMJ 328(7433):189CrossRef
19.
go back to reference Gallagher C, Hendriks JM, Mahajan R, Middeldorp ME, Elliott AD, Pathak RK, Sanders P, Lau DH (2016) Lifestyle management to prevent and treat atrial fibrillation. Expert Rev Cardiovasc Ther 14(7):799–809CrossRef Gallagher C, Hendriks JM, Mahajan R, Middeldorp ME, Elliott AD, Pathak RK, Sanders P, Lau DH (2016) Lifestyle management to prevent and treat atrial fibrillation. Expert Rev Cardiovasc Ther 14(7):799–809CrossRef
20.
go back to reference Euteneuer F, Dannehl K, Rey AD, Engler H, Schedlowski M, Rief W (2017) Immunological effects of behavioral activation with exercise in major depression: an exploratory randaomized controlled trial. Transl Psychiatry 7(5):e1132CrossRef Euteneuer F, Dannehl K, Rey AD, Engler H, Schedlowski M, Rief W (2017) Immunological effects of behavioral activation with exercise in major depression: an exploratory randaomized controlled trial. Transl Psychiatry 7(5):e1132CrossRef
21.
go back to reference Risom SS, Zwisler AD, Sibilitz KL, Rasmussen TB, Taylor RS, Thygesen LC, Madsen TS, Svendsen JH, Berg SK (2020) Cardiac rehabilitation for patients treated for atrial fibrillation with ablation has hong term-effects: 12- and 24-month follow-up results from the randomized CopenHeart(RFA) trial. Arch Phys Med Rehabil 101(11):1877–1886CrossRef Risom SS, Zwisler AD, Sibilitz KL, Rasmussen TB, Taylor RS, Thygesen LC, Madsen TS, Svendsen JH, Berg SK (2020) Cardiac rehabilitation for patients treated for atrial fibrillation with ablation has hong term-effects: 12- and 24-month follow-up results from the randomized CopenHeart(RFA) trial. Arch Phys Med Rehabil 101(11):1877–1886CrossRef
22.
go back to reference Malmo V, Nes BM, Amundsen BH, Tjonna A, Stoylen A, Rossvoll O, Wisloff U, Loennechen JP (2016) Aerobic interval training reduces the burden of atrial fibrillation in the shor term: a rondomized trail. Circulation 133(5):466–473CrossRef Malmo V, Nes BM, Amundsen BH, Tjonna A, Stoylen A, Rossvoll O, Wisloff U, Loennechen JP (2016) Aerobic interval training reduces the burden of atrial fibrillation in the shor term: a rondomized trail. Circulation 133(5):466–473CrossRef
23.
go back to reference Kato M, Ogano M, Mori Y, Kochi K, Morimoto D, Kito K, Green FN, Tsukamoto T, Kubo A, Takagi H, Tanabe J (2019) Exercise-based cardiac rehabilitation for patients with catheter ablation for persistent atrial fibrillation: a randomized controlled clinical trial. Eur J Prev Cardiol 26(18):1931–1940CrossRef Kato M, Ogano M, Mori Y, Kochi K, Morimoto D, Kito K, Green FN, Tsukamoto T, Kubo A, Takagi H, Tanabe J (2019) Exercise-based cardiac rehabilitation for patients with catheter ablation for persistent atrial fibrillation: a randomized controlled clinical trial. Eur J Prev Cardiol 26(18):1931–1940CrossRef
24.
go back to reference Miake J, Kato M, Ogura K, Iitsuka K, Okamura A, Tomomori T, Tsujimoto D, Masahiko Kato M, Yamamoto K (2019) Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after raduifrequency catheter ablation in patients with nonvalvular atrial fibrillation. Heart Vessels 34(3):517–526CrossRef Miake J, Kato M, Ogura K, Iitsuka K, Okamura A, Tomomori T, Tsujimoto D, Masahiko Kato M, Yamamoto K (2019) Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after raduifrequency catheter ablation in patients with nonvalvular atrial fibrillation. Heart Vessels 34(3):517–526CrossRef
Metadata
Title
Cardiac rehabilitation after catheter ablation of atrial fibrillation in patients with left ventricular dysfunction
Authors
Daisetsu Aoyama
Shinsuke Miyazaki
Kanae Hasegawa
Moeko Nagao
Shota Kakehashi
Moe Mukai
Takayuki Sekihara
Minoru Nodera
Tomoya Eguchi
Takayoshi Aiki
Junya Yamaguchi
Yuichiro Shiomi
Naoto Tama
Hiroyuki Ikeda
Kentaro Ishida
Hiroyasu Uzui
Hiroshi Tada
Publication date
01-10-2021
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 10/2021
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-021-01829-8

Other articles of this Issue 10/2021

Heart and Vessels 10/2021 Go to the issue